Market Research Logo

Japan Duchenne Muscular Dystrophy Market Research Report 2018

Japan Duchenne Muscular Dystrophy Market Research Report 2018

This report studies the Duchenne Muscular Dystrophy market status and outlook of Japan and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in Japan and major regions, and splits the Duchenne Muscular Dystrophy market by product type and applications/end industries.

The major players in Japan Duchenne Muscular Dystrophy market include
PTC Therapeutics
Sarepta Therapeutics
Bristol-Myers Squibb
ITALFARMACO
BioMarin
Daiichi Sankyo
Solid Biosciences
Summit Therapeutics
FibroGen
NS Pharma
Pfizer
ReveraGen BioPharma
Wave Life
Genethon
Santhera Pharmaceuticals

Geographically, this report is segmented into several key Regions, with consumption, revenue, market share and growth rate of Duchenne Muscular Dystrophy in these regions, from 2013 to 2025 (forecast), covering
Kanto
Hokkaido & Tohoku
Chubu
Kyushu
Others

On the basis of product, the Duchenne Muscular Dystrophy market is primarily split into
Deflazacort
Prednisone
Others

On the basis on the end users/applications, this report covers
Male
Female


1 Duchenne Muscular Dystrophy Overview
1.1 Product Overview and Scope of Duchenne Muscular Dystrophy
1.2 Classification of Duchenne Muscular Dystrophy by Product Category
1.2.1 Japan Duchenne Muscular Dystrophy Revenue Comparison by Types (2013-2025)
1.2.2 Japan Duchenne Muscular Dystrophy Revenue Market Share by Types in 2017
1.2.3 Prednisone
1.2.4 Deflazacort
1.3 Japan Duchenne Muscular Dystrophy Market by Applications/End Users
1.3.1 Male
1.3.2 Female
1.4 Japan Duchenne Muscular Dystrophy Market by Regions
1.4.1 Japan Duchenne Muscular Dystrophy Market Size Comparison by Regions (2013-2025)
1.4.2 Kanto Duchenne Muscular Dystrophy Status and Prospect (2013-2025)
1.4.3 Hokkaido & Tohoku Duchenne Muscular Dystrophy Status and Prospect (2013-2025)
1.4.4 Chubu Duchenne Muscular Dystrophy Status and Prospect (2013-2025)
1.4.5 Kyushu Duchenne Muscular Dystrophy Status and Prospect (2013-2025)
1.5 Japan Market Size of Duchenne Muscular Dystrophy (2013-2025)
2 Global Duchenne Muscular Dystrophy Market Competition by Players/Manufacturers
2.1 Global Duchenne Muscular Dystrophy Sales and Market Share of Key Players/Manufacturers (2017-2018)
2.2 Global Duchenne Muscular Dystrophy Revenue and Share by Players/Manufacturers (2017-2018)
2.3 Global Duchenne Muscular Dystrophy Average Price by Players/Manufacturers (2017-2018)
2.4 Global Market Size of Duchenne Muscular Dystrophy (2013-2018)
2.5 Global Players/Manufacturers Duchenne Muscular Dystrophy Headquarters, Established Date and Product Types
3 Japan Duchenne Muscular Dystrophy Revenue by Regions (2013-2018)
4 Japan Duchenne Muscular Dystrophy Revenue by Type/ Product Category (2013-2018)
4.1 Japan Duchenne Muscular Dystrophy Revenue and Market Share by Type (2013-2018)
4.2 Japan Duchenne Muscular Dystrophy Revenue Growth Rate by Type (2013-2018)
5 Japan Duchenne Muscular Dystrophy Revenue by Application (2013-2018)
5.1 Japan Duchenne Muscular Dystrophy Revenue and Market Share by Applications (2013-2018)
5.2 Japan Duchenne Muscular Dystrophy Revenue Growth Rate by Applications (2013-2018)
6 Analysis of Duchenne Muscular Dystrophy Industry Key Manufacturers
6.1 PTC Therapeutics
6.1.1 Company Profile
6.1.2 Product Information
6.1.3 Sales, Price, Cost, Gross, and Revenue
6.2 Sarepta Therapeutics
6.2.1 Company Profile
6.2.2 Product Information
6.2.3 Sales, Price, Cost, Gross, and Revenue
6.3 Bristol-Myers Squibb
6.3.1 Company Profile
6.3.2 Product Information
6.3.3 Product Name and Clinical Stage
6.4 ITALFARMACO
6.4.1 Company Profile
6.4.2 Product Information
6.4.3 Product Name and Clinical Stage
6.5 BioMarin
6.5.1 Company Profile
6.5.2 Product Information
6.5.3 Product Name and Clinical Stage
6.6 Daiichi Sankyo
6.6.1 Company Profile
6.6.2 Product Information
6.6.3 Product Name and Clinical Stage
6.7 Solid Biosciences
6.7.1 Company Profile
6.7.2 Product Information
6.7.3 Product Name and Clinical Stage
6.8 Summit Therapeutics
6.8.1 Company Profile
6.8.2 Product Information
6.8.3 Product Name and Clinical Stage
6.9 FibroGen
6.9.1 Company Profile
6.9.2 Product Information
6.9.3 Product Name and Clinical Stage
6.10 NS Pharma
6.10.1 Company Profile
6.10.2 Product Information
6.10.3 Product Name and Clinical Stage
6.11 Pfizer
6.11.1 Company Profile
6.11.2 Product Information
6.11.3 Product Name and Clinical Stage
6.12 ReveraGen BioPharma
6.12.1 Company Profile
6.12.2 Product Information
6.12.3 Product Name and Clinical Stage
6.13 Wave Life
6.13.1 Company Profile
6.13.2 Product Information
6.13.3 Product Name and Clinical Stage
6.14 Genethon
6.14.1 Company Profile
6.14.2 Product Information
6.14.3 Product Name and Clinical Stage
6.15 Santhera Pharmaceuticals
6.15.1 Company Profile
6.15.2 Product Information
6.15.3 Product Name and Clinical Stage
7 Duchenne Muscular Dystrophy Manufacturing Cost Analysis
7.1 Duchenne Muscular Dystrophy R&D Cost Analysis
7.1.1 Clinical Phase Costs
7.1.2 Capitalized Costs
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.2.1 USA Labor Cost Analysis
7.2.2.2 Europe Labor Costs Analysis
7.2.2.3 Asia Labor Costs Analysis
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Duchenne Muscular Dystrophy
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Duchenne Muscular Dystrophy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 Japan Duchenne Muscular Dystrophy Market Size Forecast (2019-2025)
11.1 Japan Duchenne Muscular Dystrophy Revenue Forecast (2019-2025)
11.2 Japan Duchenne Muscular Dystrophy Revenue Forecast by Type (2019-2025)
11.3 Japan Duchenne Muscular Dystrophy Revenue Forecast by Application (2019-2025)
11.4 Japan Duchenne Muscular Dystrophy Revenue Forecast by Regions (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Product Picture of Duchenne Muscular Dystrophy
Figure Japan Duchenne Muscular Dystrophy Revenue (M USD) and Growth Rate Comparison by Types (Product Category) (2013-2025)
Figure Japan Duchenne Muscular Dystrophy Revenue Market Share by Types in 2017
Figure Pain Management Drugs Product Picture
Figure Corticosteroids Product Picture
Table Japan Duchenne Muscular Dystrophy Revenue (M USD) Comparison by Applications (2013-2025)
Figure Japan Revenue Market Share of Duchenne Muscular Dystrophy by Applications in 2017
Figure Male Examples
Figure Female Examples
Table Japan Duchenne Muscular Dystrophy Market Size Comparison by Regions (2013-2025)
Figure Kanto Duchenne Muscular Dystrophy Revenue (M USD) and Growth Rate (2013-2025)
Figure Hokkaido & Tohoku Duchenne Muscular Dystrophy Revenue (M USD) and Growth Rate (2013-2025)
Figure Chubu Duchenne Muscular Dystrophy Revenue (M USD) and Growth Rate (2013-2025)
Figure Kyushu Duchenne Muscular Dystrophy Revenue (M USD) and Growth Rate (2013-2025)
Figure Japan Duchenne Muscular Dystrophy Revenue (M USD) and Growth Rate (2013-2025)
Table Global Duchenne Muscular Dystrophy Sales (K Dose) of Key Players/Manufacturers (2017-2018)
Table Global Duchenne Muscular Dystrophy Sales Market Share by Players/Manufacturers (2017-2018)
Table Global Duchenne Muscular Dystrophy Revenue (M USD) by Players/Manufacturers (2017-2018)
Table Global Duchenne Muscular Dystrophy Revenue Market Share by Players/Manufacturers (2017-2018)
Table Global Market Duchenne Muscular Dystrophy Average Price (USD/Dose) of Key Players/Manufacturers (2017-2018)
Figure Global Duchenne Muscular Dystrophy Revenue (M USD) and Growth Rate (2013-2025)
Table Japan Players/Manufacturers Duchenne Muscular Dystrophy Headquarters and Established Date
Table Japan Players/Manufacturers Duchenne Muscular Dystrophy Product Category and Stage
Table Mergers & Acquisitions, Expansion
Table Japan Duchenne Muscular Dystrophy Revenue (M USD) and Market Share by Regions (2013-2018)
Table Japan Duchenne Muscular Dystrophy Revenue Market Share by Regions (2013-2018)
Figure Japan Duchenne Muscular Dystrophy Revenue Market Share by Regions (2013-2018)
Figure Japan Duchenne Muscular Dystrophy Revenue Market Share by Regions in 2013
Figure Japan Duchenne Muscular Dystrophy Revenue Market Share by Regions in 2017
Table Japan Duchenne Muscular Dystrophy Revenue (M USD) and Market Share by Type (2013-2018)
Table Japan Duchenne Muscular Dystrophy Revenue Market Share by Type (2013-2018)
Figure Revenue Market Share of Duchenne Muscular Dystrophy by Type (2013-2018)
Figure Revenue Market Share of Duchenne Muscular Dystrophy by Type in 2013
Figure Revenue Market Share of Duchenne Muscular Dystrophy by Type in 2017
Figure Japan Duchenne Muscular Dystrophy Revenue Growth Rate by Type (2013-2018)
Table Japan Duchenne Muscular Dystrophy Revenue (M USD) by Applications (2013-2018)
Table Japan Duchenne Muscular Dystrophy Revenue Market Share by Applications (2013-2018)
Figure Japan Duchenne Muscular Dystrophy Revenue Market Share by Applications (2013-2018)
Figure Japan Duchenne Muscular Dystrophy Revenue Market Share by Applications in 2013
Figure Japan Duchenne Muscular Dystrophy Revenue Market Share by Applications in 2017
Figure Japan Duchenne Muscular Dystrophy Revenue Growth Rate by Applications (2013-2018)
Table PTC Therapeutics Company Profile
Figure Duchenne Muscular Dystrophy Product Picture of PTC Therapeutics
Table Duchenne Muscular Dystrophy Sales (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of PTC Therapeutics 2017-2018
Table Sarepta Therapeutics Company Profile
Figure Duchenne Muscular Dystrophy Product Picture of Sarepta Therapeutics
Table Duchenne Muscular Dystrophy Sales (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Sarepta Therapeutics 2017-2018
Table Bristol-Myers Squibb Company Profile
Table Duchenne Muscular Dystrophy Product Name and Clinical Stage of Bristol-Myers Squibb
Table ITALFARMACO Company Profile
Table Duchenne Muscular Dystrophy Product Name and Clinical Stage of ITALFARMACO
Table BioMarin Company Profile
Table Duchenne Muscular Dystrophy Product Name and Clinical Stage of BioMarin
Table Daiichi Sankyo Company Profile
Figure Duchenne Muscular Dystrophy Product Picture of Daiichi Sankyo
Table Duchenne Muscular Dystrophy Product Name and Clinical Stage of Daiichi Sankyo
Table Solid Biosciences Company Profile
Figure Duchenne Muscular Dystrophy Product Picture of Solid Biosciences
Table Duchenne Muscular Dystrophy Product Name and Clinical Stage of Solid Biosciences
Table Summit Therapeutics Company Profile
Table Duchenne Muscular Dystrophy Product Name and Clinical Stage of Summit Therapeutics
Table FibroGen Company Profile
Figure Duchenne Muscular Dystrophy Product Picture of FibroGen
Table Duchenne Muscular Dystrophy Product Name and Clinical Stage of FibroGen
Table NS Pharma Company Profile
Figure Duchenne Muscular Dystrophy Product Picture of NS Pharma
Table Duchenne Muscular Dystrophy Product Name and Clinical Stage of NS Pharma
Table Pfizer Company Profile
Figure Duchenne Muscular Dystrophy Product Picture of Pfizer
Table Duchenne Muscular Dystrophy Product Name and Clinical Stage of Pfizer
Table ReveraGen BioPharma Company Profile
Figure Duchenne Muscular Dystrophy Product Picture of ReveraGen BioPharma
Table Duchenne Muscular Dystrophy Product Name and Clinical Stage of ReveraGen BioPharma
Table Wave Life Company Profile
Figure Duchenne Muscular Dystrophy Product Picture of Wave Life
Table Duchenne Muscular Dystrophy Product Name and Clinical Stage of Wave Life
Table Genethon Company Profile
Figure Duchenne Muscular Dystrophy Product Picture of Genethon
Table Duchenne Muscular Dystrophy Product Name and Clinical Stage of Genethon
Table Santhera Pharmaceuticals Company Profile
Table Duchenne Muscular Dystrophy Product Name and Clinical Stage of Santhera Pharmaceuticals
Figure Typical Phases from Research to the Market for a drug Candidate
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
Table Manufacturing Cost Structure of Duchenne Muscular Dystrophy
Figure Assessment of API Manufacturing Cost By Region
Figure USA Overview of Average Hourly Wages 2015-2016 (USD/Hour)
Figure USA Overview of Labor Costs 2013-2016 (110 Index Points)
Figure Cost of Employing a Factory Worker
Figure 2015 Estimated Labor Costs for the Whole Economy in Europe
Figure Monthly Minimum Wages in Asia 2016
Figure China Overview of Average Yearly Wages 2015-2016 (CNY/Year)
Figure Japan Overview of Average Monthly Wages 2015-2016(JPY Thousand/Month)
Table 2015 Global Electricity Price of Industry (USD/KWh) by Country
Figure Manufacturing Process Analysis of Duchenne Muscular Dystrophy
Figure Duchenne Muscular Dystrophy Industrial Chain Analysis
Table Major Buyers of Duchenne Muscular Dystrophy
Figure Setting Pricing Policy
Figure PMO Structure
Figure RNA Structure
Figure Next-generation Chemistries
Figure Global GDP Growth Rate for 2016
Figure Real GDP Growth 2016-2020 annual Average
Figure US GDP 2006-2016 (Billion USD)
Figure US CPI Change 2017-2018
Figure EU GDP 2008-2016 (Billion USD)
Figure EU CPI Change 2017
Figure Germany GDP 2008-2016 (Billion USD)
Figure Germany CPI Change 2017-2018
Figure UK GDP 2008-2016 (Billion USD)
Figure UK CPI Change 2016-2017
Figure Italy GDP 2008-2016 (Billion USD)
Figure Italy CPI Change 2017-2018
Figure Japan GDP 2008-2016 (Billion USD)
Figure Japan CPI Change 2017
Figure China GDP 2008-2016 (Billion USD)
Figure China CPI Change 2017-2018
Figure Japan Duchenne Muscular Dystrophy Revenue (M USD) and Growth Rate Forecast (2019-2025)
Table Japan Duchenne Muscular Dystrophy Revenue (M USD) Forecast by Type (2019-2025)
Table Japan Duchenne Muscular Dystrophy Revenue Market Share Forecast by Type (2019-2025)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report